Outcomes of extended total mesorectal excision in patients with locally advanced rectal cancer.
Srivishnu SaravanabavanMufaddal M KaziJanesh MuruganTejas VisputePreeti VijayakumaranAshwin L DesouzaAvanish P SaklaniPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
The recurrence pattern, R1 resection rate and survival outcomes of patients in the present study were comparable with those for patients undergoing an exenteration. Therefore, eTME is probably a safe alternative to pelvic exenterations when R0 resection is achievable and when the procedure is performed in high-volume specialist tertiary care centres.
Keyphrases
- rectal cancer
- locally advanced
- patients undergoing
- tertiary care
- end stage renal disease
- neoadjuvant chemotherapy
- phase ii study
- newly diagnosed
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- palliative care
- radiation therapy
- patient reported outcomes
- type diabetes
- metabolic syndrome
- prognostic factors
- lymph node
- free survival